๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Multimodality therapy of favorable prognosis non-hodgkin's lymphoma

โœ Scribed by Michael P. Corder; Joseph T. Leimert; Hamed H. Tewfik; Jan M. Lovett

Publisher
Elsevier Science
Year
1983
Tongue
English
Weight
427 KB
Volume
9
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Therapy of non-Hodgkin's lymphoma
Therapy of non-Hodgkin's lymphoma
โœ J. Coffey; D. C. Hodgson; M. K. Gospodarowicz ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Springer ๐ŸŒ English โš– 160 KB
Interferon therapy of non-Hodgkin's lymp
Interferon therapy of non-Hodgkin's lymphoma
โœ Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 459 KB ๐Ÿ‘ 2 views

In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar

Favorable prognosis after late relapse o
Favorable prognosis after late relapse of hodgkin's disease
โœ R. Garcia-Carbonero; L. Paz-Ares; A. Arcediano; J. Lahuerta; A. Bartolome; H. Co ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 2 views

The authors express their gratitude to all the members of the Medical Oncology, Hematology, Radiotherapy, and Pathology Divisions at the Hospital Universitario Doce de Octubre for their collaboration. They also thank Prof. W. P. Steward for critical reviewing of the article.